Kala Bio, Inc. (KALA)
0.57
+0.03
(+5.97%)
USD |
NASDAQ |
Sep 09, 13:39
Kala Bio Total Assets (Quarterly) : 10.58M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.58M |
| March 31, 2026 | 12.32M |
| December 31, 2025 | 9.49M |
| September 30, 2025 | 25.02M |
| June 30, 2025 | 36.05M |
| March 31, 2025 | 48.25M |
| December 31, 2024 | 55.48M |
| September 30, 2024 | 54.08M |
| June 30, 2024 | 61.61M |
| March 31, 2024 | 53.03M |
| December 31, 2023 | 55.95M |
| September 30, 2023 | 61.12M |
| June 30, 2023 | 66.50M |
| March 31, 2023 | 72.23M |
| December 31, 2022 | 86.82M |
| September 30, 2022 | 85.70M |
| June 30, 2022 | 84.98M |
| March 31, 2022 | 111.57M |
| December 31, 2021 | 139.43M |
| September 30, 2021 | 193.81M |
| June 30, 2021 | 215.46M |
| March 31, 2021 | 229.83M |
| December 31, 2020 | 221.61M |
| September 30, 2020 | 225.10M |
| Date | Value |
|---|---|
| June 30, 2020 | 245.51M |
| March 31, 2020 | 258.53M |
| December 31, 2019 | 154.32M |
| September 30, 2019 | 161.01M |
| June 30, 2019 | 178.82M |
| March 31, 2019 | 197.02M |
| December 31, 2018 | 220.97M |
| September 30, 2018 | 84.08M |
| June 30, 2018 | 95.59M |
| March 31, 2018 | 104.99M |
| December 31, 2017 | 116.13M |
| September 30, 2017 | 123.69M |
| June 30, 2017 | 28.59M |
| March 31, 2017 | 37.61M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 8.448M |
| September 30, 2015 | 12.65M |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 11.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.538M |
| Shareholders Equity (Quarterly) | 9.044M |
| Current Ratio | 6.880 |
| Net Debt Paydown Yield | 19.34% |